John Pasi
University of North Carolina at Chapel Hill · 233 works · 15,858 citations · h-index 58
Top works
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)
- Haemophilias A and B
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- Functional definition and characterization of acute traumatic coagulopathy
- Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
- The incidence and magnitude of fibrinolytic activation in trauma patients
- Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
- Factor IX Inhibitors and Anaphylaxis in Hemophilia B
- Epidemiology and pathophysiology of cancer-associated thrombosis
- Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease
- Transmission of Human Parvovirus B19 by Coagulation Factor Concentrates
- Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
- Performance of the platelet function analyser PFA-100?? in testing abnormalities of primary haemostasis
- Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
- Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
- Experiences with continuous infusion of recombinant activated factor VII.